Biofarm S.A.

BVB-BIO
Bucharest Stock Exchange
Pharmaceutical Preparations
Global Rank
#20781
Country Rank
#28
Market Cap
192.55 M
Price
0.195
Change (%)
0.12%
Volume
332,700

Biofarm S.A.'s latest marketcap:

192.55 M

As of 08/19/2025, Biofarm S.A.'s market capitalization has reached $192.55 M. According to our data, Biofarm S.A. is the 20781th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 192.55 M
Revenue (ttm) 71.09 M
Net Income (ttm) 18.71 M
Shares Out 985.37 M
EPS (ttm) 0.02
Forward PE 0.00
Ex-Dividend Date 08/18/2025
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 08/19/2025

Biofarm S.A.'s yearly market capitalization.

Biofarm S.A. has seen its market value grow from 306.67 M RON to 835.59 M RON since 2014, representing a total increase of 172.47% and an annual compound growth rate (CAGR) of 9.88%.
Date Market Cap Market Cap(USD) Change (%) Global Rank
08/19/2025 835.59 M $192.55 M 22.97% 20781
12/30/2024 703.55 M $146.12 M -13.35% 20885
12/29/2023 811.94 M $179.8 M 33.77% 19460
12/30/2022 606.99 M $131.17 M -26.14% 20562
12/30/2021 821.8 M $188.45 M 94.86% 19185
12/30/2020 421.74 M $105.81 M 17.91% 20283
12/30/2019 357.69 M $83.61 M 11.69% 19054
12/31/2018 320.24 M $78.68 M 11.3% 18514
12/29/2017 287.73 M $73.55 M 8.15% 19601
12/30/2016 266.05 M $61.74 M -4.26% 18305

Company Profile

About Biofarm S.A.

Biofarm S.A. is a leading Romanian pharmaceutical company specializing in the manufacture and sale of medicines. Established in 1921 and headquartered in Bucharest, the company serves both domestic and international markets.

Product Portfolio

Biofarm offers a diverse range of pharmaceutical products across multiple therapeutic areas, including:

  • Antiallergics
  • Cardiovascular and circulatory
  • Analgesics and antipyretics
  • Dermatology
  • Digestive and metabolic
  • Endocrine
  • Genitourinary
  • Multivitamins
  • Ophthalmology
  • Musculoskeletal
  • Respiratory and ENT
  • Neurology

Product Categories

The company provides:

  • Prescription and non-prescription medicines
  • Food supplements
  • Medical devices
  • Cosmetics
  • Other healthcare products

Global Reach

In addition to serving the Romanian market, Biofarm exports its products to several countries, including:

  • Azerbaijan
  • Albania
  • Georgia
  • Iraq
  • Kyrgyzstan
  • Hungary
  • Republic of Moldova

Frequently Asked Questions

  • What is Biofarm S.A.'s (BVB-BIO) current market cap?
    As of 08/19/2025, Biofarm S.A. (including the parent company, if applicable) has an estimated market capitalization of $192.55 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Biofarm S.A. global market capitalization ranking is approximately 20781 as of 08/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.